Podcasts about Verve

Text the Wedding Planning HotlineYour wedding flowers are so much more than decoration. They set the tone, tell your story, and turn your reception into a space guests will never forget. In this episode, we're revisiting one of our most-loved conversations: how to choose the perfect flowers for your wedding day. From statement arrangements to subtle details you never knew you needed, I'm sharing insider tips to help you make thoughtful, stylish decisions with total confidence.We'll cover how to find a floral style that feels authentic to you, what to consider when balancing beauty and budget, and ways to incorporate blooms that make your celebration truly personal. Whether you've been dreaming in peonies since childhood or you're just starting to think about centerpieces, this episode will give you the tools to work with your florist like a pro and create a cohesive, stunning floral design that elevates every moment.If you're ready to bring your vision to life with a planner who understands your priorities, inquire at verveeventco.com to learn more about working with Verve.Links Mentioned in the EpisodeFind the Full Shownotes HereGrab Our Day of Master OrganizerGrab Our Wedding Budget BundleGrab our Ultimate Wedding Planning Checklist Book a 90-minute Clarity Call to get wedding planning help specific to your unique situationVisit the ASK THE PLANNER Wedding Planning Templates Shop Connect with the show!

We review Aster Instant Coffee from Verve and discuss how instant music has ruined everything, more roommate drama, and people delaying growing up.

Jean Olson, age 70, describes her 13 years in the Foreign Service as an “odd and torturous path,” that included a successful class action suit against the federal government. Jean left the Foreign Service (stints in Europe and South America) for her hometown in Wisconsin to be her mother's caregiver and to serve as (volunteer) President of the Village Council. At age 57, and ‘unemployed' for seven years, Jean created a path to retirement. She rejoined the Foreign Service for seven more years, having to start over as a “baby diplomat” — a “lesson in humility.”  Jean choice of Las Cruces, NM. as her retirement home affords her access to a university, a cluster of good friends, affordable housing, and excellent Mexican restaurants. Best of all--no snow shoveling! Since her move, Jean has served on the Board of the New Mexico Farm and Ranch Heritage Museum, worked with a Refugee Resettlement project, and is currently engaged with a children's Literacy program. When I retired from the Foreign Service, I found a home in New Mexico with a university, good friends, affordable housing, and great Mexican restaurants. - Jean OlsonConnect with Jean Email: jean.olson@yahoo.com 

James, Weezer, Green Day, The Verve.

Tęsiame britpopo muzikos apžvalgą – prisiminsime ne tik žymiausius šio žanro atstovus, bet ir savo laiku mažiau įvertintas grupes bei originaliausius scenos veidus. Taip pat – keletas pastebėjimų apie grupės Oasis sugrįžimo koncertus.Grojaraštyje: Kula Shaker, Elastica, The Verve, Sleeper, Ocean Colour Scene, Supergrass ir kiti.Ved. Lukas Devita

Corrientes Circulares 15x40 FINAL DE TEMPORADA con noticias y novedades sobre Love of Lesbian, Mute, Placebo, Zenttric, Iván Ferreiro, The Smiths, Jamie XX, The Verve, Nosoträsh, Elyella ft Siloé y Los Planetas!!! Dale al play!!!

Corrientes Circulares 15x40 FINAL DE TEMPORADA con noticias y novedades sobre Love of Lesbian, Mute, Placebo, Zenttric, Iván Ferreiro, The Smiths, Jamie XX, The Verve, Nosoträsh, Elyella ft Siloé y Los Planetas!!! Dale al play!!!

Corrientes Circulares 15x40 FINAL DE TEMPORADA con noticias y novedades sobre Love of Lesbian, Mute, Placebo, Zenttric, Iván Ferreiro, The Smiths, Jamie XX, The Verve, Nosoträsh, Elyella ft Siloé y Los Planetas!!! Dale al play!!!

【喜歡這個Set? 歡迎加入國民電音新生活！】

Why Your Leadership Mindset is the Ultimate Crisis Tool In today's unpredictable world, leadership is more critical than ever. But how do you lead effectively when the ground is shifting beneath your feet? We dove deep with David Johnson, a veteran leader and CEO of Verve, to uncover the core principles of leading through economic uncertainty. His advice boils down to one powerful truth: it starts with your mindset. The biggest mistake a leader can make is inaction. David emphasizes that waiting for the storm to pass only wastes precious time and opportunity. A true leader breaks down overwhelming problems into manageable pieces and gets the team moving. This isn't about reckless action; it's about embracing small, continuous progress that builds confidence and momentum.  

סיפורו של המאסטרפיס שהתחיל מסמפול פשוט של הרולינג סטונז - והפך לאחד המחטפים המכוערים בתולדות המוזיקה

Ross Barkan is a 35 year-old American journalist and novelist from Bay Ridge, Brooklyn. His third novel, Glass Century, was published on 6 May 2025.On a semi-vacation to London this summer, Ross and Jack met to speak about Ross's favourite Martin Amis novel, Inside Story.This the first episode of the series to deal explicitly, and at length, with Donald Trump.Looking beyond the playful concept of 'The Maggot Probability' (first coined by Kingsley Amis to explain the degenerative effects of an ageing brain), Ross and Jack discuss Amis's graver concerns about true impact of America's septuagenarian president on its politics and political culture.As a New Yorker, Ross recognises what he calls Trump's "outer-borough mindset", an attitude of adversity towards the elites of Manhattan who famously paid Trump little serious attention before his meteoric rise to office in 2016 forced them to.That mindset, he argues, became Trump's calling card to the left behind of America, for whom Washington had come to represent the same den of iniquity and aloofness that the gleaming towers of The Big Apple had to Trump in the 70s and 80s.And yet, while Amis does not take Trump lightly, Ross says his criticisms of Trump lack the corrosive power of the pen that Amis was otherwise known for. Amis confesses to taking an arch tone on the subject in Inside Story, though says he does so only because Trump is a "sick joke".It's suggested later in the conversation that while Amis excelled at diagnosing modern pathologies in characters like John Self, he may have bottled it when it came to confronting the real thing in Trump. Does it take a true New Yorker to satirise this century's most controversial Western leader? It may help to read Ross's new novel before answering.Finally, listen to this episode to discover what Ross took as indispensable writing advice from Amis in Inside Story.FOLLOW US ON TWITTER/ X: @mymartinamisFIND US ON YOUTUBE Hosted on Acast. See acast.com/privacy for more information.

Sintonía: "Wait Till You See Her" - Ella Fitzgerald"Spanish Grease" - Willie Bobo; "Is You Is Or Is You Ain´t My Baby?" - Dinah Washington; "Feeling Good" y "See-Line Woman" - Nina Simone; "Don´t Explain" y "Strange Fruit" - Billie Holiday; "Return to Paradise" - Shirley Horn.Todas las canciones extraídas del CD "Verve // Unmixed" (Verve, 2002/Universal, 2003)"See-Line Woman" (Masters At Work Remix) - Nina Simone; "Summertime" (UFO Remix) - Sarah Vaughan; "How Long Has This Been Going On?" (MJ Cole Remix) - Carmen McRaeTodas las remezclas extraídas del CD "Verve // Remixed" (Verve, 2002/Universal 2003)Bonus track: "Who Needs Forever" - Astrud Gilberto Escuchar audio

(!!!unbeauftrag und unbezahlte Werbung!!!)In dieser Episode der Lesebühne sprechen wir mit Andrea Hudak, einer begabten Opern- und Konzertsängerin. Sie teilt ihren faszinierenden Weg in der Musik und erzählt Anekdoten aus ihrem Leben auf und hinter der Bühne. Andrea reflektiert über den Einfluss ihrer Familie sowie ihre Leidenschaft für die Oper, die letztlich zur Entstehung ihres Buches „Keine Sorge, wir machen das zum ersten Mal“ führte. Gemeinsam mit ihrer musikalischen Partnerin Yuki Inagawa bringt sie humorvolle und herzerwärmende Geschichten ihrer Karriere näher, einschließlich unerwarteter Herausforderungen bei Auftritten und skurriler Anfragen. Andrea beleuchtet zudem die Unterschiede zwischen Musik und Schreiben und hebt die Bedeutung des Geschichtenerzählens in ihrer Kunst hervor.Geboten wird ein humorvoller Blick hinter die Kulissen des Künstleralltags + dessen Herausforderungen. Die Kunst wird vom Podest der Erhabenheit gehoben. Das zeigt, was wir vor uns haben: ein HandwerkÜber die Autorin:Die Sängerin hat sich mit Bühnenanekdoten hervorgetan, schreibt elegant; rezitiert mit Verve und singt mit Überzeugungskraft. Sie ist Botschafterin der sich durchdringenden Künste Musik und Literatur.SocialMedia & Websitewww.sopranissimo.deInstagram: https://www.instagram.com/andreachudakFacebook: Andrea ChudakJetzt reinhören.---Meine LesungEin Podcast in dem Autoren ihre Bücher, und auch sich selbst vorstellen.Du als Leser, mit Interesse an Lesungen, kommst voll auf deine Kosten. Finden für dich interessante Lesungen nicht in deiner näheren Umgebung statt? Dann ist dieser Podcast genau das Richtige für dich. Hier stellen diverse Autoren ihre Bücher im Rahmen einer Lesung vor. Ein paar Fragen zum Autor und seinem Buch dürfen natürlich nicht fehlen. Der Podcast kommt in einem wöchentlichen Rhythmus und bietet ein riesiges Portfolio an Autoren bzw. Buch-Lesungen.  Du kannst diesen Podcast auch kostenlos mit der App deiner Wahl abonnieren. Sobald es eine neue Folge gibt, wird diese zum anhören bereitgestellt. Alle Einzelheiten und Informationen unter https://meinelesung.de.Bist du AutorIn oder Autor und möchtest dein Buch in meinem Podcast vorstellen? Aufnahmen sind per Telefon, Skype, FaceTime, Zoom oder bei einem gemütlichen und persönlichen Zusammensitzen möglich. Melde dich ganz einfach bei mir, und wir können vorab alle Einzelheiten besprechen.Weitere Einzelheiten, Informationen und Kontaktmöglichkeiten unter https://meinelesung.de.Dir gefällt dieser Podcast? Dann empfehle ihn weiter und lass eine kleine Bewertung in den entsprechenden Portalen da, wie zum Beispiel Apple Podcasts (iTunes) oder Podcast.de.Herzlichen Dank. SocialMedia:website: https://meinelesung.deInstagram: https://www.instagram.com/meinelesungfacebook: https://www.facebook.com/meineLesungYouTube: https://www.youtube.com/@meinelesungPodcast AbonnementRSS-Feed: https://pcr.apple.com/id1484505215

Delve into this classic 1990's record with me.

Featuring brand new music from Erik Deutsch's upcoming release “This Was Then'; a meeting of legendary guitar minds between Charlie Hunter and Ella Feingold; Joe Alterman and Mocean Worker paying tribute to the one of the greatest, Les McCann; BK psycho-funk geniuses Breastfist; a visit to the electric roots of NYC legend Phil Haynes; the final recording of late Japanese master Ryuichi Sakamoto; a new look at the Bill Evans Trio from the Verve vault; and the creme de la creme of France, Air.

Aron! is only 22, but his music seems to exist outside of time. A singer, songwriter, and multi-instrumentalist from North Carolina, he studied classical guitar, jazz voice, and film scoring—playing everything from indie rock in a college band to Nat King Cole covers in retirement homes—before landing on a sound that feels both old school and strikingly fresh. (He calls his sound “vintage pop”.) His debut EP cozy you (and other nice songs) began as a self-produced student project, recorded in a college studio with friends. It was completed before he signed with Verve Records—one of the most iconic jazz labels in the world—and showcases his gift for timeless songwriting, intimate performance, and warm, sophisticated arrangements. He first gained attention online through casual videos of himself playing standards and originals, quietly amassing a loyal audience. Among his early champions was Ryan Lerman (Scary Pockets), who helped connect Aron! with a wider musical community. Here he reflects on his musical roots, his love of old songs, the strange path from Instagram to Verve, and the challenge of staying grounded in a moment of rapid change. The songs may sound old, but the feeling is immediate. The muse, it seems, doesn't care what year it is. www.third-story.com www.leosidran.substack.com www.wbgo.org/podcast/the-third-story

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former FDA official Peter Marks criticized the agency's new risk-based COVID-19 vaccine framework, stating it contradicts the administration's transparency and science standards. The CDC's advisory committee recommended Merck's infant RSV vaccine, and Novavax's approval delay raised concerns about politicization of drug approval processes. Lilly's Verve deal revealed regulatory turmoil following Marks' resignation. Meanwhile, Trump's CDC pick supports vaccine safety, Novartis made a large bet on cardiovascular disease targets, and RFK cut US funding from vaccine alliance Gavi. The biopharma industry is hiring less international talent, and pharma companies face challenges with failed immuno-oncology projects. Evotec is hosting a webinar on preserving quality in the pharmaceutical industry.

Publicly traded U.K. investment firm and company builder Syncona is restructuring its fund amid ongoing market challenges in the biopharma industry. On the latest BioCentury This Week podcast, BioCentury's analysts discuss how the firm will steer its portfolio toward returns for shareholders, while aiming to build a new fund away from public markets. The analysts then assess Eli Lilly's takeout of cardiovascular base editing company Verve, and what Washington Editor Steve Usdin calls FDA's new “two-track” future for evaluating new therapies for approval — those with clear-cut benefits and those with ambiguous efficacy safety and efficacy profiles — in light of the many departures of senior FDA staff. They also discuss NASDAQ's largest biopharma IPO — by Caris —  in two years, the latest obesity readouts, FDA Commissioner Marty Makary's priority pathway and Usdin's Q&A with new BIO Chair Fritz Bittenbender. This episode of BioCentury This Week was sponsored by ICON Biotech.View full story: https://www.biocentury.com/article/656266#biotech #biopharma #pharma #lifescience #finance #CV #FDA00:01 - Sponsor Message: ICON Biotech02:14 - Syncona Restructures Fund10:08 - Lilly's $1B Verve Takeout21:45 - FDA's 2-Track FutureTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Prima una capatina a Carnaby Street (tempio della "Swinging London" anni '60), poi un salto a Camden Town in compagnia dei punk '70. Nel mezzo: una passeggiata a Hoxton Street col britpop nelle cuffie, una serata nella movida notturna '80s del West End, e tanto altro.Insomma, nel nuovo episodio ho provato a fare un viaggio virtuale attraverso le epoche della Londra musicale... Instagram: https://www.instagram.com/swing_out_faber/Spotify: https://spoti.fi/2yxp5xCApple: https://apple.co/2WAUcjKSpreaker: https://www.spreaker.com/show/suono-ma-nessuno-apreGrafica di Daris Nardini: https://instagram.com/thedarside?igshid=YmMyMTA2M2Y=

Today is new music Monday with Singer Songwriter Jonah Paz of the San Diego band Please Pill.  If you like Britpop from the early 90's like Oasis, The Verve and Blur you are no doubt gonna love Pleasure Pill.  Today I sit down with Jonah Paz the lead singer/songwriter of Pleasure Pill and talk all about their new record out this Friday June 27th 2025 called Hang A Star. Enjoy my friends and help spread the word. My Tour Dates can be found here - https://www.deandelray.com/tourdates Support my podcast by joining my Patreon https://www.deandelray.com/patreon My New Comedy Special 5836 can be seen for free right here https://www.deandelray.com/ Like and Subscribe for more PODCASTS AND COMEDY VIDEOS from Dean Delray!

Audio roundup of selected biopharma industry content from Scrip over the business week ended June 20, 2025. In this episode: US policies in spotlight at BIO; Lilly's Verve acquisition; UroGen's bladder cancer approval; Ireland's biopharma talent; and Korea proposes new AI R&D project. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-VYWYRS37HJH6HNRZJHNGCWVSNM/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Howie and Harlan discuss health and healthcare issues making headlines, including public attitudes toward the Medicaid cuts in the budget bill making its way through Congress, a one-time gene therapy that could cure high cholesterol, “ambient” AI in the exam room, and the replacement of the the CDC's entire vaccine advisory board.  Links: Remembering Atul Butte “Atul Butte, a biomedical and bioinformatics pioneer, dies at 55” Marina Sirota on LinkedIn “Remembering Atul Butte, MD, PhD” The Budget Bill H.R.1—One Big Beautiful Bill Act “KFF Health Tracking Poll: Views of the One Big Beautiful Bill” CBO: Dynamic Estimate of H.R. 1, One Big Beautiful Bill Act “Protesters disrupt town-hall healthcare talks” Vinay Prasad “Vinay Prasad named chief medical and science officer at FDA” “Critic of drug industry and COVID-19 measures to lead FDA vaccine program” Medicaid Cuts “Senate GOP tax bill would hit politically explosive Medicaid provision” “The Senate Wants Billions More in Medicaid Cuts, Pinching States and Infuriating Hospitals” “5 Key Facts About Medicaid Work Requirements” “Georgia Touts Its Medicaid Experiment as a Success. The Numbers Tell a Different Story.” “Georgia's Pathways to Coverage Program: The First Year in Review” “Trump's Big Bill Would Be More Regressive Than Any Major Law in Decades” Gene Therapy to Prevent Heart Disease Verve Therapeutics Verve Therapeutics: Sekar Kathiresan, M.D. “Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push” “Viral Vector-Based Gene Therapy” “mRNA-based therapeutics: powerful and versatile tools to combat diseases” “Second patient death reported with gene therapy for muscular dystrophy” Anti-Vaxxers at the CDC “Scoop: CDC has no Acting Director, sources confirm.” Video: Robert F. Kennedy Jr. on the polio vaccine “This tech millionaire went from covid trial funder to misinformation superspreader” “Kennedy Removes All C.D.C. Vaccine Panel Experts” “RFK Jr. replaced everyone on the CDC's vaccine panel. Here's why that matters” “ACIP, CDC, and Insurance Coverage of Vaccines in the United States” Ambient AI “Ambient AI Is Having Its ‘Moment' In Healthcare” “This technology is becoming beloved by doctors and patients alike” “Physician Perspectives on Ambient AI Scribes” “Microsoft unveils new voice-activated AI assistant for doctors” “Kaiser Permanente rolls out Abridge's gen AI clinical tech across 40-hospital system” “Andreessen Horowitz in Deal Talks Valuing Abridge AI at $5.3 Billion” “Abridge easing clinician workload”

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Ey's 2025 Biotech Beyond Borders report reveals that over one-third of biotech companies have less than a year of cash left, indicating financial challenges within the industry. The report emphasizes the need for a return to basics for biotech companies. Additionally, industry experts are discussing FDA Commissioner Makary's push to modernize the FDA and speed up regulatory processes. Scholar Rock has seen positive results with a weight loss combination therapy, and the FDA's new voucher program has been met with some optimism from biotech investors. Overall, the biotech industry is facing financial struggles, but there are opportunities for growth and innovation in the future.BioNTech and CureVac were once enemies, with BioNTech attacking CureVac's "failed" COVID vaccine program. However, they are now merging, with BioNTech buying CureVac in a $1.25 billion all-stock acquisition. The biopharma industry has seen a string of dramatic deals, with companies paying high premiums for acquisitions. This includes Sanofi paying a 300% premium for Vigil Neuroscience and Novartis acquiring Regulus for $800 million upfront. Overseas biosimilars companies can be sued in the US, potentially dissuading them from targeting the US market and benefiting domestic producers. Lilly's $1.3 billion acquisition of Verve in the gene editing space has been met with skepticism from analysts. Biotechs are seeking partnerships as the industry moves forward, with events like BIO2025 kicking off. The industry is facing challenges such as layoffs at companies like Lycia, while AstraZeneca makes a $5.3 billion AI bet with China's CSPC for chronic disease pills. Overall, the biopharma industry is experiencing a period of intense deal-making and strategic shifts.

- Simple Plan célèbre ses 25 ans dans un documentaire - Yungblud reprend "Bitter Sweet Symphony" de The Verve en session live - Lola Young annonce son nouvel album prévu pour septembreDistribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Howie and Harlan discuss health and healthcare issues making headlines, including public attitudes toward the Medicaid cuts in the budget bill making its way through Congress, a one-time gene therapy that could cure high cholesterol, “ambient” AI in the exam room, and the replacement of the the CDC's entire vaccine advisory board.  Links: Remembering Atul Butte “Atul Butte, a biomedical and bioinformatics pioneer, dies at 55” Marina Sirota on LinkedIn “Remembering Atul Butte, MD, PhD” The Budget Bill H.R.1—One Big Beautiful Bill Act “KFF Health Tracking Poll: Views of the One Big Beautiful Bill” CBO: Dynamic Estimate of H.R. 1, One Big Beautiful Bill Act “Protesters disrupt town-hall healthcare talks” Vinay Prasad “Vinay Prasad named chief medical and science officer at FDA” “Critic of drug industry and COVID-19 measures to lead FDA vaccine program” Medicaid Cuts “Senate GOP tax bill would hit politically explosive Medicaid provision” “The Senate Wants Billions More in Medicaid Cuts, Pinching States and Infuriating Hospitals” “5 Key Facts About Medicaid Work Requirements” “Georgia Touts Its Medicaid Experiment as a Success. The Numbers Tell a Different Story.” “Georgia's Pathways to Coverage Program: The First Year in Review” “Trump's Big Bill Would Be More Regressive Than Any Major Law in Decades” Gene Therapy to Prevent Heart Disease Verve Therapeutics Verve Therapeutics: Sekar Kathiresan, M.D. “Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push” “Viral Vector-Based Gene Therapy” “mRNA-based therapeutics: powerful and versatile tools to combat diseases” “Second patient death reported with gene therapy for muscular dystrophy” Anti-Vaxxers at the CDC “Scoop: CDC has no Acting Director, sources confirm.” Video: Robert F. Kennedy Jr. on the polio vaccine “This tech millionaire went from covid trial funder to misinformation superspreader” “Kennedy Removes All C.D.C. Vaccine Panel Experts” “RFK Jr. replaced everyone on the CDC's vaccine panel. Here's why that matters” “ACIP, CDC, and Insurance Coverage of Vaccines in the United States” Ambient AI “Ambient AI Is Having Its ‘Moment' In Healthcare” “This technology is becoming beloved by doctors and patients alike” “Physician Perspectives on Ambient AI Scribes” “Microsoft unveils new voice-activated AI assistant for doctors” “Kaiser Permanente rolls out Abridge's gen AI clinical tech across 40-hospital system” “Andreessen Horowitz in Deal Talks Valuing Abridge AI at $5.3 Billion” “Abridge easing clinician workload”

Snillen spekulerar i dagens avsnitt - först om amerikanska patenttvister och sedan om internationella relationer. Dessutom stablecoins, en dag med goda nyheter för evolution innan det smattrar in dåliga nyheter igen, och en skum riktad i Verve.(Ungefärliga) tidsstämplar:02:30 Neonode $NEON11:48 Evolution $EVO13:50 Verve Group $VER19:20 Stablecoins blir mainstream22:50 Israel/Iran - Tankers $ECO $FRO $INSW $LPG $ZIM—X: https://twitter.com/marketmakerspod Kontakt: podcast@marketmakers.se Hemsida: https://www.marketmakers.se/ Niklas, Fabian och Magnus finns förstås också på X:https://twitter.com/alden_niklas https://twitter.com/franzen_fabian https://twitter.com/analytikern1234 Samt Bluesky:https://bsky.app/profile/aldenniklas.bsky.social https://bsky.app/profile/fabianfranzen.bsky.social https://bsky.app/profile/magnusskoog.bsky.social Hosted on Acast. See acast.com/privacy for more information.

Les classiques du jour : - The Shoes "Time To Dance" - Foo Fighters "Everlong" Les nouveautés du jour : - Suede "Trance State" - Marcus King "Carolina Honey" - Nxdia "Body On Me" Le journal de la musique : - Simple Plan célèbre ses 25 ans dans un documentaire - Yungblud reprend "Bitter Sweet Symphony" de The Verve en session live - Lola Young annonce son nouvel album prévu pour septembre La cover : Blondie reprend "Ring Of Fire" de Johnny Cash (Live from "The Roadie", 1980) Le live du jour : Kate Bush "Running Up That Hill" (J.O. Londres, 2012) Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

This episode is brought to you by Better Beer. TRAINING WEEKS
 The 2025 FTK podcast hosts are back together are giving up their spot for last week's FTK OG takeover. Jack cracks 160km in his 3x key workout week at Font Romeu where he spends plenty of time training with Sondre Moen (2:05:48 Marathon PB). Joel does another big mileage week that sees him running more often than he's used to and unfortunately for him a fair bit slower than he's used to (especially at this weekend's Ferny Creek run). Tess updates the listeners on the medical issue that surfaced in an MRI which explained why she needed to play it safe and skip some runs later in the week. THE BIG Q
 Tess asks Jack and Joel their opinion on how to coach an athlete that is struggling for motivation this deep into a marathon block. The team discuss a variety of answers that should help the athlete enjoy their upcoming race without the pressure of a pre-negotiated "goal time". GIVE SOME KUDOS 
 Jack sends his Kudos to an incredibly fast runner while Tess uses self-reflection during this short period of injury to give kudos. Joel goes left of centre and sends his in the direction of Uranium glass. TWHSOITWTWATSA
 Tess is not sure about a certain promotional video seen on the Verve socials. Jack submits his entry which is an interview from a Villanova athlete before his 5000m at the NCAA champs. Joel can't decide between two this week so he does the noble thing and submits both. One recipient has received this award numerous times throughout the season while the second submission is of an anonymous poster of the Facebook page Athletes Australia wanting advice on what super shoes to buy their 9 year old child.   SIGN UP TO OUR PATREON TODAY: www.patreon.com/forthekudos Instagram: https://www.instagram.com/forthekudos Facebook: https://www.facebook.com/forthekudos TikTok: https://www.tiktok.com/@forthekudos Jack: https://www.instagram.com/jackrayner7 Joel: https://www.instagram.com/joeltobinblack Tess: https://www.instagram.com/tesssicaa_

Pat Angeli du 16-20 RFM vous raconte en quelques minutes l'histoire d'un titre, d'un album ou d'un artiste mythique !Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Je leest het goed. De rijkste man van de wereld heeft miljarden nodig. Geld dat 'ie gebruikt om zijn AI-imperium uit te bouwen. Het moet dé concurrent worden van OpenAI. Een bedrijf dat dan weer écht in oorlog ligt met Microsoft.We hebben het er deze aflevering over. Dan hebben we het ook over die echte oorlog. Die tussen Israël en Iran. In Iran smeken ze president Trump om een wapenstilstand in te lassen, maar daar heeft hij geen trek in. Waardoor de onzekerheid op de beurs (voor jou) nog langer aanhoudt.We ontdekten trouwens dat het ondanks die oorlog prima beleggen is in Tel Aviv. Nou ja prima. Fantastisch. Waarom dat is, je raadt het al: daarvoor moet je toch echt luisteren.Hoor je ook meer over een miljardenovername van Eli Lilly en de handelsdeal die Trump heeft gesloten met de EU. Of was het nu met het Verenigd Koninkrijk? See omnystudio.com/listener for privacy information.

Send us a textVox of the Chameleons stops by to discuss his long career, his evolution, their new record, the world, and more. *****Having released their first studio recordings in over 20 years in 2024 (Where Are You? of new material and Tomorrow Remember Yesterday which consisted of re-recorded archival tracks), Chameleons have been gearing up the release of their upcoming album Arctic Moon later 2025 which will be their first studio full-length since 2001's Why Call It Anything. He explains, "It's quite different from anything Chameleons has done before, and I know this will probably polarize the legacy audience, but we're quite excited about how it's developing. I think the songwriting is much more mature in a lot of ways, which is to be expected, I suppose, given our age, but I, for one, really believe we're taking the band forward, and I'm quite excited about it."  Not planning on playing too much from the new album (“we don't really want the songs spoiling on such platforms as YouTube until the record is actually out”), the new album will undoubtedly be embraced by old and new fans alike. “Our approach to making the music hasn't changed,” Vox hints, “although having found a regular producer in Christophe Bride at Oxygene has helped our development tremendously. His studio in Manchester, UK, is a great environment to work in. We feel our sound is fresher and more contemporary, which seems to resonate very strongly with our younger audience that are turning out to see us in such great numbers.”  Long cited as a hugely influential act, having inspired the likes of Verve, Oasis, White Lies, The Slow Readers Club, Interpol, The Killers and Editors, among countless others and known for their transformative musical catalog and intense and emotionally charged live performances, Chameleons have created a legacy that extends beyond their four studio albums. Following their debut single "In Shreds" in 1982, the band released three seminal albums: the widely acclaimed Script of the Bridge (1983), cited by many sources as a masterpiece way ahead of its time, and its follow-up, What Does Anything Mean? Basically!' (1984), Strange Times (1986), and Why Call It Anything? (2001). Their unique sound quickly captivated the public through their mix of melancholic yet energetic and powerful tunes, hypnotic, ethereal riffs, and the potent, timeless lyrical style. Chameleons are considered one of the most influential guitar bands of the 80s and 90s, contributing substantially to the post-punk, shoegaze, and indie scenes. They are often regarded as one of the most underrated bands ever to emerge from Manchester, England. Chameleons are Reg Smithies (guitar), Vox (bass, vocals, lyrics), Stephen Rice (guitar), Danny Ashberry (keyboards), and Todd Demma (drums).******If you would like to contact the show about being a guest, please email us at Dauna@bettertopodcast.comUpcoming guests can be found: https://dmneedom.com/upcoming-guest Follow us on Social MediaInstagram: https://www.instagram.com/author_d.m.needom/Facebook: https://www.facebook.com/bettertopodcastwithdmneedomIntro and Outro music compliments of Fast Suzi©2025 Better To...Podcast with D. M. NeedomSupport the show

Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback II CRT vs CSP – CONSYST-CRT • Trial JACC EP https://doi.org/10.1016/j.jacep.2025.03.024 III The Important QRS • Kewcharoen et al https://www.ahajournals.org/doi/10.1161/CIRCEP.125.013809 IV ABYSS Trial of BB Interruption after MI Continues to be Mis-interpreted • ABYSS Main https://www.nejm.org/doi/full/10.1056/NEJMoa2404204 • ABYSS substudy https://doi.org/10.1093/eurheartj/ehaf170 • REDUCE AMI https://www.nejm.org/doi/full/10.1056/NEJMoa2401479 V Oral PCSK9i and the PURSUIT Trial • Koren et al https://www.jacc.org/doi/10.1016/j.jacc.2025.03.499 • Editorial https://doi.org/10.1016/j.jacc.2025.03.518 • Is Lifelong LDL-C Lowering Within Reach? The heart-1 Gene-Editing Trial https://www.medscape.com/viewarticle/998162 • Heart-1 Gene Therapy Trial Pauses Enrollment https://www.medscape.com/viewarticle/998162 • EHJ coverage VERVE https://academic.oup.com/ehjcvp/article/10/2/87/7455877 VI Cardiac Sarcoidosis and Risk of VT • EHJ paper Mathijssen et al https://doi.org/10.1093/eurheartj/ehaf338 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Sometimes it doesn't feel safe to bring our full, authentic self to work. In this episode, our guest Amy Ewbank, co-CEO of Verve The Voice Advisory Service, shares what's holding you back and the three key elements you need to find and express your true voice in a professional setting.   01:38 Understanding the Barriers to Authentic Voice 02:27 The Three E's Framework: Essence, Expression, Environment 02:45 Essence: Aligning Values and Voice 03:46 Expression: The Art of Speaking and Storytelling 04:35 Environment: Creating Safe Spaces for Voice 13:03 The Importance of Finding Your Voice 17:18 The Power of Community in Voice Development 22:06 Practical Tips for Self-Awareness and Voice Improvement   ✅ Connect with Amy Ewbank:  Verve Company  website Verve Voice Diagnostic / Quiz Amy LinkedIn Lily LinkedIn  Verve LinkedIn  Instagram Handle  Amy Ewbank - @amyewbs Instagram Handle Lily - @lily_lapenna Company Instagram Handle - @verveleaders   Email: To Learn more about joining the Verve Global Voice community email Amy on connect@verveleaders.com to arrange a free discovery call so she can share more about the programme and how Verve can support you in finding and honing your authentic voice.    About Amy: Amy Ewbank is a leadership coach, communication strategist, and expert in voice identity, drawing from her dual background as a LAMDA trained actor and CIPD qualified HR / L&D professional. With a career spanning the creative industries and corporate leadership, Amy has worked at the intersection of performance, psychology, and workplace communication, helping individuals and organisations harness the power of voice for influence, presence, and impact. Amy began her career as a professional actor, performing in repertory theatre, BBC Radio, and Channel 4. She later transitioned into leadership and learning, becoming Head of HR at a UK national charity, where she specialized in talent development and executive communication. She has been featured on Sky News, Channel 5 and The Guardian.   About Verve: Verve is The Voice Advisory Service for courageous professionals ready to master the why, when and how of using your voice. We offer coaching, masterclasses, and community—shaped by our 3 E's Voice Methodology™ - Essence, Expression, and Environment—to help you speak with clarity, lead with presence, and communicate with Verve.   ✅ Free Newsletter: https://assertiveway.com/newsletter/   ✅ Listen on the Speak Your Mind Unapologetically podcast on Apple Itunes: https://podcasts.apple.com/us/podcast/speak-your-mind-unapologetically-podcast/id1623647915      ✅ Listen on Spotify: https://open.spotify.com/show/6L1myPkiJXYf5SGrublYz2   ✅ Order our book, ‘Unapologetic Voice: 101 Real-World Strategies for Brave Self Advocacy & Bold Leadership' where each strategy is also a real story: https://www.amazon.com/Unapologetic-Voice-Real-World-Strategies-Leadership-ebook/dp/B0CW2X4WWL/   ✅ Follow the show host, Ivna Curi, on LinkedIn: https://www.linkedin.com/in/ivna-curi-mba-67083b2/     ✅ Request A Customized Workshop For Your Team And Company:   http://assertiveway.com/workshops Contact me: info@assertiveway.com or ivnacuri@assertiveway.com Contact me on Linkedin: https://www.linkedin.com/in/ivna-curi-mba-67083b2   ✅ Support The Podcast Rate the podcast on apple: https://podcasts.apple.com/us/podcast/speak-your-mind-unapologetically-podcast/id1623647915

Enjoy our discussion of The Verve's "A Storm In Heaven."

This won't be the last time you hear the Rolling Stones but this is the episode wherein we discuss "The Last Time" from early 1965. After acknowledging the chorus copped from the Staple Singers, we move on to the riff, the riff, the riff! We also note the strange connection to German Oompah music. The second in the parade comes from their producer and manager Andrew Oldham and his Orchestra. Obviously, this is a rearrangement rather than a cover, and obviously, it's infamous in the wake of Verve's "Bittersweet Symphony." It's totally tubular! In '66 to North Carolina's Nomads gave the song the garage treatment and the vocals are snottier and the kick drum is busier! The same year Phil & The Frantics authored a version with strange strangled vocals, an added organ with "Gloria" flourishes and it's the most oompah of all. We break the mold for "Do You Understand Me" by The Jujus, a song which steals the riff but scrambles it a bit - it's a classic! The last word goes the Who, who covered the song in 67 who underplay the riff and focus on Pete Townshend's thundering chords and Keith Moon's wild drumming. Oompah!

The I Love CVille Show headlines: Jefferson Council Lists 7 Reasons To Fire Jim Ryan Is This Jim Ryan's 2nd Most Challenging Period? Federal Executive Institute Protest At 5:30 PM Today Eight Months Later, CVille Has A City Attorney Amazon Fulfillment Center Will Create 1,000 Jobs Double Edged Sword Of Amazon Economic Development Old Ivy Residences vs. Verve vs. Blume – What's Best? Charlottesville Business Brokers Has Cash Buyers Read Viewer & Listener Comments Live On-Air The I Love CVille Show airs live Monday – Friday from 12:30 pm – 1:30 pm on The I Love CVille Network. Watch and listen to The I Love CVille Show on Facebook, Instagram, Twitter, LinkedIn, iTunes, Apple Podcast, YouTube, Spotify, Fountain, Amazon Music, Audible, Rumble and iLoveCVille.com.

The I Love CVille Show headlines: Are City School Board & Teachers' Union Adversaries? What Has Caused Divisiveness Like FEI Debacle 70% Of City School Employees Live In CVille/AlbCo Numbers Do Not Show Teachers Fleeing To Outer Counties UVA Loses $60M+ In Federal Research Cuts CVille Biz Spotlight: Al Carbon Has It Dialed In Old Ivy Residences vs. Verve vs. Blume – What's Best? Charlottesville Business Brokers Has Cash Buyers Read Viewer & Listener Comments Live On-Air The I Love CVille Show airs live Monday – Friday from 12:30 pm – 1:30 pm on The I Love CVille Network. Watch and listen to The I Love CVille Show on Facebook, Instagram, Twitter, LinkedIn, iTunes, Apple Podcast, YouTube, Spotify, Fountain, Amazon Music, Audible, Rumble and iLoveCVille.com.

This season we discuss over 300 albums of the 1990s selected from https://besteveralbums.com. The show starts at (1:44). The Six Singles segment starts at (5:29). This episode covers the following albums: Steve Earle - El Corazon (41:47), Missy Elliott - Supa Dupa Fly (1:04:20), Blur - Blur (1:24:26), and The Verve - Urban Hymns (1:51:27).Check out our YouTube page here: http://www.youtube.com/@combingthestacks1470Check out the Combing the Stacks Letterboxd list here: https://boxd.it/bS98c

Welcome to the Health Marketing Collective, where strong leadership meets marketing excellence. In today's episode, host Sara Payne sits down with Mike Cronin, Cofounder and Chief Strategist at Verve, to explore the evolving landscape of creativity in B2B healthcare marketing. Mike, whose impressive résumé includes brand and campaign strategy for UnitedHealth Group, Blue Cross Blue Shield, Optum, and revered consumer brands like Harley-Davidson and Samuel Adams, brings a rare blend of creative vision and strategic rigor to his work. His fundamental belief? That creative work's purpose is to move people, not just fill space. In this conversation, Mike and Sara dive deep into how B2B health brands can move beyond “safe” ideas and unlock emotionally resonant, unforgettable campaigns—even within highly regulated and risk-averse spaces. They discuss why simplicity is a superpower, the importance of strategic “boxes,” and how marketing leaders can create environments where big swings are encouraged, not stifled. Along the way, Mike shares memorable stories from his work (including a campaign that fused Lizzo's “Good as Hell” into healthcare advertising), offers insight into the universal human truths marketers often miss, and outlines what separates teams that produce great creative from those that simply make noise. Thank you for being part of the Health Marketing Collective, where strong leadership meets marketing excellence. The future of health care depends on it. Key Takeaways: Creativity Thrives Within Constraints: Mike challenges the conventional wisdom of “thinking outside the box.” He argues that true creativity is often unlocked not by limitless freedom, but by well-defined strategic constraints. It's within the confines of a focused brief—what Mike calls “the freedom of a tight brief”—that intelligent, emotionally resonant ideas emerge. Rather than aiming for “crazy” or “flashy,” the best creative is smart, intentional, and purpose-driven. Emotion and Human Truth are Universal, Even in B2B: B2B often gravitates toward rational benefits: cost savings, efficiency, or productivity. But, as Mike notes, even financial administrators and clinicians are humans first—they respond to messages that tap into universal emotions and experiences: hope, fear, dignity, and relief from frustration. Brands that connect on this human level, rather than just touting features and benefits, become memorable and meaningful. Strategic Alignment is the Key to Unlocking Great Creative: Teams that produce truly breakthrough work consistently prioritize strategy. When everyone is aligned on the core insight and brief, creativity can flow freely within those parameters. Conversely, weak or vague direction leads to “safe,” generic campaigns. Mike's experience shows that great creative always starts with a shared, sharp strategic foundation. Boldness is Essential for Breaking Through the Noise: Healthcare, especially B2B, often defaults to playing it safe (“everything's blue”)—but in a crowded marketplace, standing out is non-negotiable. Mike advocates for boldness that is grounded in the brand's truth and strategically anchored. The result: unforgettable, not just noisy, marketing. Leadership's Role: Foster Honesty, Empathy, and Trust: Leadership sets the tone for creativity and trust. Mike urges CMOs and marketing leaders to lead with clarity and honesty—eschewing “BS” and toxic positivity for real, truthful dialogue about challenges and opportunities. Teams (and audiences) respond to authenticity; when leaders call things as they are and create space for truth, better work results. Resources and Contact: Want to connect with Mike or learn more about Verve's approach to strategic creativity? Visit

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Pfizer has dropped its lead obesity molecule, danuglipron, due to safety concerns regarding liver issues, leaving the company with only one molecule in its obesity pipeline. This decision has raised questions about the future direction of Pfizer's obesity research. Additionally, there are fears about the impact of recent firings at the Department of Health and Human Services on the FDA, with concerns about delays in drug approvals and increased political influence on regulatory decisions.In other news, Verve's base editor showed promise in lowering bad cholesterol levels in a phase Ib trial, and there are ongoing legal battles between Vanda and the FDA over off-label use of a drug for jet lag. Overall, the biotech industry is facing challenges and uncertainties in light of recent developments.The FDA is facing an uncertain future following a major overhaul by Kennedy, which included staff cuts that could threaten user fees, nearly half of the FDA's budget. Drug review delays and increased executive oversight are expected, with fears mounting about the agency's future direction. AI is enabling the development of smart antibodies that can more precisely target cancer cells while sparing healthy tissues.Upcoming FDA actions include a cell-based gene therapy for a rare skin disease and product expansions for Regeneron and Sanofi. Experts are concerned that FDA layoffs could trigger a mechanism that may set the industry back 35 years. Other news includes the FDA replacing some animal testing with AI and human 'organoid' lab models, changing attitudes towards the MMR vaccine, recent approvals in colorectal cancer, and more.Readers are encouraged to provide feedback on what topics they would like to see covered next.

Hocus Focus Mix met Brainpower, Justin Timberlake, Kris Kross, House of Pain, Måneskin & The Verve

To, ahem, sever himself from the news, Greg Olear brings on his wife, Stephanie St. John, a huge fan of “Severance,” to discuss the second season. Cold Harbor, fetid moppet, devour feculence, Helly/Helena, the Glasgow Block, ORTBO, the four tempers, and more goats than anyone asked for: they cover it all, with verve and wiles. Subscribe to The Five 8:https://www.youtube.com/channel/UC0BRnRwe7yDZXIaF-QZfvhACheck out ROUGH BEAST, Greg's new book:https://www.amazon.com/dp/B0D47CMX17ROUGH BEAST is now available as an audiobook:https://www.audible.com/pd/Rough-Beast-Audiobook/B0D8K41S3T Would you like to tell us more about you? http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=short

Will Callan is starring as Sebastian in Cruel Intentions: The '90s Musical.Following its London run at The Other Palace, Cruel Intentions is currently touring the UK and Ireland. Based on the 1999 film and inspired by Les Liaisons Dangereuses, Cruel Intentions features ‘90s pop classics including songs by Britney Spears, Boyz II Men, Christina Aguilera, TLC, R.E.M., Ace of Base, Natalie Imbruglia, The Verve, *NSYNC and many more.Will came to theatre via the music world and participating in The Voice Kids (ITV). He toured the UK & Ireland as Marius in Les Misérables and later reprised his performance in the West End.In this episode, Will discusses all-things Cruel Intentions, his path into theatre and his time in Les Misérables.Cruel Intentions tours until 28th June 2025. Visit www.cruelmusical.co.uk for info and tickets.This podcast is hosted by Andrew Tomlins @AndrewTomlins32 Thanks for listening! Email: andrew@westendframe.co.uk Visit westendframe.co.uk for more info about our podcasts. Hosted on Acast. See acast.com/privacy for more information.

You might be thinking… wait, what?!Get the behind the scenes details on how and why I launched a podcast production agency under the name Verve!Hit play to hear the journey, which starts all the way back in 2013.Whether you're a new listener or have been here for years, thanks for the love and support as things morph, improve, and at times PIVOT.Ready to go on your own journey into podcast management? Learn more by attending the 20 minute free training at http://LaurenWrighton.com/trainingAnd start your 30 day FREE trial of Audible by going to https://laurenwrighton.com/audibleAll other links and resources mentioned in this episode can be found at https://laurenwrighton.com/episode256Thanks for being here!

Featuring Brooklyn funk geniuses Breastfist; the continuing introspective growth of brilliant reedsman Shabaka feat. Esperanza Spalding; a talented young group with a clear vision, Saturn Quartet; brilliant stuff from the latest Verve reissue of Ella Fitzgerald's 1967 concert at the Oakland Coliseum; new music from drum master Billy Hart on the ECM label; another ECM release—this time it's outtakes from the vault delving into the brilliant concert of Keith Jarrett and his trio at the Deer Head Inn; and finally the master of the telecaster, Jim Campilongo and his singular style and sound.

This week's #locationweekly Verve & Experian team-up on cross-channel targeting, Google released a set of AI tools for fashion/beauty visualization, Heineken recruiting the next owner of an Irish pub and Struggling, Amazon merges GO and FRESH teams. Tune in now!

Jason Brenner is the RVP of Healthcare & Lifesciences at LiveRamp and has been working in the advertising and ad tech industries for over 20 years. He is leading efforts on building data connectivity solutions for the healthcare and life sciences industries. Prior to LiveRamp, Jason has held leadership positions at Placed, Verve, PayPal, Time Inc., The New York Times, and Condé Nast. In this episode… Companies in industries like healthcare and life sciences are leveraging data collaboration to collect valuable insights to drive innovation and improve customer experiences. However, for many organizations, balancing data collaboration with privacy, security, and regulatory compliance obligations remains a significant challenge. With consumer trust at stake, and the risks of improper data handling, how can companies balance innovation with responsible data use? Data collaboration in healthcare presents both opportunities and challenges. Companies need to adopt privacy-by-design principles and engage legal and privacy teams early in the process. By implementing techniques such as data tokenization and de-identification, businesses can extract valuable insights while minimizing privacy and security risks. That's why companies like LiveRamp are making this process easier with a platform that transforms personally identifiable information into non-reversible tokens, allowing organizations to use data responsibly while minimizing privacy and security risks. In this episode of She Said Privacy/He Said Security, Jodi and Justin Daniels speak with Jason Brenner, RVP of Healthcare and Life Sciences at LiveRamp, about the critical role of privacy and security in data collaboration. Jason shares insights on how organizations are navigating a complex and fragmented regulatory landscape, the importance of adopting privacy-by-design principles, and engaging legal and privacy teams early in the process. He also shares how businesses can minimize data retention risks, the role of de-identification and tokenization in protecting sensitive information, and the importance of building customer trust through responsible data practices.

Send us a textSummary: How do you strike the perfect balance between automation and human connection in customer service? In this episode of the Customer Success Playbook, hosts Roman Trebon and Kevin Metzger sit down with David Singer, Global VP at Verve, to explore the critical role emotional intelligence (EQ) plays in customer interactions. Dave shares compelling stories and practical insights on when automation should step aside to let human empathy shine. From AI-driven escalation detection to real-world examples of EQ saving the customer experience, this conversation is packed with actionable takeaways for business leaders.Detailed Analysis: Customer service is evolving fast, but one thing remains constant: customers want to feel heard. David Singer dives deep into the interplay between automation and human interaction, highlighting that while self-service tools are invaluable, there are moments when a real human connection is irreplaceable. He walks us through the nuances of identifying these moments—whether through journey mapping, intuition, or advanced AI tools that detect emotional shifts in real time.Dave illustrates his points with vivid anecdotes: a well-timed call from an online car retailer, an empathetic insurance agent cementing lifelong customer loyalty, and AI tools that recognize when an agent is emotionally drained. His key message? Emotional intelligence isn't just about customer experience—it's also about empowering employees to perform at their best.For businesses looking to optimize their CX strategy, this episode offers a fresh perspective on harmonizing automation with authentic human engagement. Now you can interact with us directly by leaving a voice message at https://www.speakpipe.com/CustomerSuccessPlaybookPlease Like, Comment, Share and Subscribe. You can also find the CS Playbook Podcast:YouTube - @CustomerSuccessPlaybookPodcastTwitter - @CS_PlaybookYou can find Kevin at:Metzgerbusiness.com - Kevin's person web siteKevin Metzger on Linked In.You can find Roman at:Roman Trebon on Linked In.

On this episode of the Hemp Podcast, we speak with Jeff Kostuik, of Verve Seed Solutions, aa Canadian Hemp Seed company based in Saskatchewan. Jeff joins us from the road—literally, from an airport—on his way to North Carolina for a meeting with a hemp processor. We'll hear about Verve Seed Solutions and the new varieties they are bringing to the hemp space this year. We will also talk about Donald Trump's impeding trade wars and what Canadian hemp businesses like Verve are doing to face the new realities. Topics Covered: How Verve Seeds genetics are distributed worldwide Increasing hemp seed yield by up to 190%  How U.S. policies are affecting Canadian farmers Navigating strict cannabinoid limits in poultry feeds Why more infrastructure is needed us US Hemp processing Learn more: Verve Seed Solutions     Thanks to our sponsors: IND HEMP KING'S AGRI-SEEDs AMERICHANVRE CAST-HEMP Music by Tin Bird Shadow